In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

THE prehistoric “super carnivore” megalodon was bigger than previously thought, growing to a whopping 80ft and weighing 94 tons. The beast would have been four times bigger than the largest great ...

Each month, we check in on the performance of the largest US stock, bond, and active exchange-traded funds. The Morningstar US Market Index rose 1.50% during January and is up 15.49% over the past ...

Although battleships were replaced by aircraft carriers by the end of World War II, they remain a testament to a bygone era of warfare—and a symbol of their nations’ might. For nearly half a century, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...